Sensorion appoints gene therapy expert Dr Géraldine Honnet as Chief Medical Officer
(WorldNews Health)

Sensorion appoints gene therapy expert Dr Géraldine Honnet as Chief Medical Officer 19 Feb 2020 07:30 CET Company Name SENSORION ISN FR0012596468 Market Euronext Growth Symbol ALSEN New Chief Medical Officer has a deep expertise in gene therapy and small molecule clinical development across disease areas Appointment accelerates strategic move into gene therapy to potentially restore hearing Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 - ALSEN), a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the appointment of gene therapy expert Géraldine Honnet...